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Dear Sir,
Prior to clinical in vivo use of a gamma probe for sentinel
lymph node detection in a cancer patient, it is advisable for
practitioners to undergo training in the manipulation by
means of a phantom. Especially in the case of full patient
anaesthesia during surgery, e.g. for breast carcinoma, un-
necessary prolongation of anaesthesia due to inadequate
or untrained probe handling should be avoided. We have
therefore designed a convenient anatomical phantom,
based on a cooking recipe. Unusually for a nuclear medi-
cine phantom, this one is sweet and coloured.
For the cooking recipe, take an amount of commer-
cially available strawberry pudding powder appropriate
for a volume of 2 l and 24 gelatine leaves. Mix the
pudding powder with six spoonfuls of sugar. Dissolve the
powder in 100 ml of cold milk. Briefly boil 2 l of milk,
remove from the heat and add the dissolved cold milk–
pudding mixture. Return to the boil and boil for 1 min
while stirring gently. Dissolve the gelatine leaves in
100 ml cold water and gently add to the liquid pudding.
Fill up two receptacles: The first round bowl, about 5 cm
in depth and 12 cm in diameter, is supposed to anatomically
simulate themammary gland. The second basin, of round or
oval circumference and with a rather flat bottom, is sup-
posed to simulate the thoracic wall. Place both receptacles
in the refrigerator for at least 4 h. Prepare four 99mTc-
labelled ‘hot spots’: one ‘injection site’ plus three ‘sentinel
lymph nodes’. The activity of the ‘injection site’ is about
100 times higher than that of the ‘sentinel nodes’. Our
‘injection site’ has an activity of 14.8 MBq (0.4 mCi=
100%), whereas the activities of the ‘sentinel nodes’ vary
between 0.075 MBq (0.002 mCi=0.5%) and 0.150 MBq
(0.004 mCi=1%). Obtain organic capsules for phar-
macological preparations from the pharmacist. Into each
capsule, insert a tiny cotton swab labelled with 99mTc. As a
humid environment such as a pudding dissolves the cap-
sules, secure them temporarily by wrapping around a small
amount of Scotch tape. The two cold puddings, now so-
lidified, are still left in their receptacles. Insert the ‘injection
site’ capsule deeply into the breast model. Insert the
‘sentinel node’ capsules into the periphery of the thoracic
wall or the breast model. Tip the thoracic wall model from
the basin onto a plate and then carefully tip out the breast
model on top of it. The hot spots will now be well hidden in
the depths of the phantom (Fig. 1). Your humanoid phan-
tom is now ready. It is of a firm consistency and looks quite
lifelike.
Thereafter, handling of the probe may be initiated.
Training may be provided in positioning, duration of ac-
quisition, speed of movement and distance of the probe
from the phantom, as well as in technical details concerning
nuclide energy, threshold-related sensitivity, and the mean-
ing of acoustic and visual signals. Localising the ‘sentinel
node’ with the probe actually works (Fig. 1)! Due to dis-
solution of the capsule and hence dispersion of the ‘hot
spot’, the spatial resolution of the ‘sentinel node’ detection
is somewhat reduced after 30–60 min. This is why ra-
diolabelling and tipping out of the phantom should ideally
be performed just prior to probe testing. Nevertheless, the
phantom may be used for testing for up to 24 h.
Standard discoid phantoms are routinely provided by
manufacturers for evaluation of new gamma probes [1].
Humanoid phantoms of the female thorax or of the female
mammary gland have been previously described in the
management of sentinel node detection [2]. This is the
first description of a disposable phantom based on a
cooking recipe for use in scintigraphic sentinel node de-
tection. Our surgical, gynaecological and dermatological
colleagues tested the value of the phantom as an intro-
duction to the technique, and thereafter felt confident in
their ability to perform sentinel node detection in patients.
As a consequence of the training, they were able to rapid-
ly and accurately localise the radioactive sentinel node
intraoperatively. The oft-cited intraoperative learning curve
of the clinician might be shortened by use of our phantom,
to the benefit of cancer patients. In addition, we felt that
interdisciplinary collaboration was strengthened by the
training. We therefore recommend this easily reproducible
procedure to newcomers.
Finally, we are pleased to append some further com-
ments: (1) We successfully repeated the probe test using
a chocolate pudding phantom. (2) A probe test using a
gelatine-only pudding was a failure, as insertion and hiding
of the ‘sentinel node’were impossible. (3) The large cheese
cake from the baker’s store, initially ordered with a view to
radiolabelling and serving as a phantom, was instead eaten
with pleasure. Bon appetit!
Fig. 1. Tracking the radioactive ‘sentinel node’ within the humanoid
phantom with the gamma probe
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